Long-range structural defects by pathogenic mutations in most severe glucose-6-phosphate dehydrogenase deficiency

  • Naoki Horikoshi
    Life Science Center for Survival Dynamics, University of Tsukuba, Ibaraki 305-8577, Japan;
  • Sunhee Hwang
    Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305;
  • Cornelius Gati
    Biological Sciences Division, SLAC National Accelerator Laboratory, Menlo Park, CA 94025;
  • Tsutomu Matsui
    Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, CA 94025;
  • Carlos Castillo-Orellana
    Departamento de Físico-Química, Facultad de Ciencias Químicas, Universidad de Concepción, Concepción 94030000, Chile;
  • Andrew G. Raub
    Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305;
  • Adriana A. Garcia
    Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305;
  • Fatemeh Jabbarpour
    Biological Sciences Division, SLAC National Accelerator Laboratory, Menlo Park, CA 94025;
  • Alexander Batyuk
    Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025
  • Joshua Broweleit
    Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305;
  • Xinyu Xiang
    Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305;
  • Andrew Chiang
    Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305;
  • Rachel Broweleit
    Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305;
  • Esteban Vöhringer-Martinez
    Departamento de Físico-Química, Facultad de Ciencias Químicas, Universidad de Concepción, Concepción 94030000, Chile;
  • Daria Mochly-Rosen
    Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305;
  • Soichi Wakatsuki
    Biological Sciences Division, SLAC National Accelerator Laboratory, Menlo Park, CA 94025;

Search this article

Description

<jats:title>Significance</jats:title> <jats:p>Mechanism of the loss of activity of the most severe patient-derived mutants of glucose-6-phosphate dehydrogenase (G6PD) deficiency has remained elusive despite the availability of the G6PD structures for decades. Structural and biophysical investigations have revealed a common mechanism and dynamics of how these mutations hinder the substrate-binding site, reducing enzymatic activity. These are triggered by a long-distance propagation of structural defects at the dimer interface and the binding site of the noncatalytic cofactor. These structural distortions are found among all of the class I mutants investigated, providing critical clues for drug design to address G6PD deficiency by correcting the structural defects.</jats:p>

Journal

Citations (1)*help

See more

References(60)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top